Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for Severe COVID-19
NCT04530370Phase 1Unknown
- Sponsor
- South Valley University
- Start
- May 2020
- Primary completion
- Sep 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by South Valley University. Primary endpoint: Satisfactory outcome at 5 days. Status: unknown.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04530370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530370.